Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Axcan receives European marketing approval for Photobarr PDT

April 2, 2004

Potent syncretic antimitotic agent by CombinatoRx

April 2, 2004

Congress presentations report PD-0332991's biochemical, pharmacological and pharmacokinetic profile

April 1, 2004

Pladienolide D derivative, E-7107, shows good antitumor activity in xenografts

April 1, 2004

Bayer claims diagnostics and therapeutics for GPR19-associated diseases

April 1, 2004

Enrollment opens in phase III trial of STR in multiple myeloma

April 1, 2004

YM BioSciences to commence pivotal tesmilifene trial in coming weeks

April 1, 2004

NAD-299, RS-23597 active in prostate cancer cells

April 1, 2004

Atrasentan delays disease progression in metastatic prostate cancer

April 1, 2004

ECO-04601 demonstrates broad antitumor activity in various tumor cell lines

March 31, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...